Dominic Schmidt
Investitore di Private Equity presso Advent Venture Partners LLP
Profilo
Dominic joined Advent Life Sciences in April 2022 with a background in biochemistry, genomics, molecular oncology, strategy consulting and life science venture capital.
Prior to joining Advent, he spent eight years as a Partner in the investment team of Syncona, a publicly listed healthcare investment company.
During his time there he was involved in the founding, funding and building of several life science businesses and served on the Boards of Anaveon, Orbit Biomedical (merged with Gyroscope), Gyroscope Therapeutics (acquired by Novartis for up to $1.5 billion), Purespring Therapeutics and Forcefield Therapeutics.
After gaining a German Diplom Degree in Biochemistry from the Free University of Berlin and the Max Planck Institute for Molecular Genetics he received a PhD from the Department of Oncology at the University of Cambridge.
Dominic was a Cancer Research UK scholar and his research has been published in Cell, Nature and Science.
His PhD thesis was recognized with the Pontecorvo and Science & SciLife Lab Prizes.
Posizioni attive di Dominic Schmidt
| Società | Posizione | Inizio |
|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investitore di Private Equity | 01/04/2022 |
Precedenti posizioni note di Dominic Schmidt
| Società | Posizione | Fine |
|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investitore di Private Equity | 01/03/2022 |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Direttore/Membro del Consiglio | 01/03/2022 |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 01/03/2022 |
| Forcefield Therapeutics Ltd. | Direttore/Membro del Consiglio | 01/03/2022 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Direttore/Membro del Consiglio | 01/02/2022 |
Formazione di Dominic Schmidt
| University of Cambridge | Doctorate Degree |
| Freie Universität Berlin | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Finance |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Orbit Biomedical, Inc.
 Orbit Biomedical, Inc. Medical SpecialtiesHealth Technology Orbit Biomedical, Inc. engages in a healthcare company. It aims to revolutionize gene and cell therapy treatment by setting a new standard for precise, targeted surgical delivery. The company was founded by Mike Keane in 2018 and is headquartered in Ambler, PA.. | Health Technology |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
L.E.K. Consulting Group Ltd.
 L.E.K. Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services L.E.K. Consulting Group Ltd. operates as a management consulting firm. The company was founded on June 16,2017 and is headquartered in London, the United Kingdom. | Commercial Services |
Orbit Biomedical Ltd.
 Orbit Biomedical Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, Orbit Biomedical Ltd. is a British biotechnology company that engages in research and development. Part of Novartis AG, the company is based in Stevenage, UK. | Commercial Services |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Commercial Services |
| Forcefield Therapeutics Ltd. |
- Borsa valori
- Insiders
- Dominic Schmidt
